Abstract
The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer's disease.
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
